Identification and validation of alternative splicing isoforms as novel biomarker candidates in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Identification and validation of alternative splicing isoforms as novel biomarker candidates in hepatocellular carcinoma

Published:2018-12-21 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Wu Peng¹,Zhou Donghu¹,Wang Yuqian²,Lin Weiran¹,Sun Aihua¹,Wei Handong¹,Fang Yi³,Cong Xianling²,Jiang Ying¹

Affiliation:

1. State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, P.R. China

2. Department of Dermatology, China‑Japan Union Hospital, Jilin University, Changchun, Jilin 130033, P.R. China

3. Department of Endocrinology, Beijing 307 Hospital, Beijing 100070, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative Polyadenylation Regulatory Factors Signature for Survival Prediction in Kidney Renal Cell Carcinoma;Cancer Informatics;2024-01

2. Decoding the role of aberrant RNA alternative splicing in hepatocellular carcinoma: a comprehensive review;Journal of Cancer Research and Clinical Oncology;2023-10-29

3. Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression in pancreatic ductal adenocarcinoma;Functional & Integrative Genomics;2023-03-18

4. Alternative Splicing and Cancer;Nucleic Acid Biology and its Application in Human Diseases;2023

5. Comprehensive analysis of pre-mRNA alternative splicing regulated by m6A methylation in pig oxidative and glycolytic skeletal muscles;BMC Genomics;2022-12-06